A Rare Case of Mild Hemophilia A in a Female with Mosaic Monosomy X and a De Novo F8 Variant.

High Prevalence of Heterotopic Ossification in Mild Hemophilia: A Biological Inevitability or a Prophylactic Blind Spot?

Safe Outpatient Dental Management of a Pediatric Patient With Mild Hemophilia A: A Case Report.

Hemophilic Pseudotumor of the Maxilla Secondary to Endodontic Treatment: Case Report and Systematic Review.

Efanesoctocog Alfa Prophylaxis in a Patient With Combined Mild Hemophilia A and Type 1 von Willebrand Disease.

Recurrent Subdural Hematoma Revealing Undiagnosed Mild Hemophilia A and Factor XIII Deficiency in an Elderly Patient.

Genetic determinants of the complement and coagulation pathways in invasive meningococcal disease.

Advantages of FVIII-Extended Half-Life (Turoctocog Alfa Pegol) in the Management of Cardiac Surgery in a Patient with Mild Hemophilia A: A Case Report and Literature Review.

Real-World Evidence on Joint Condition in Non-Severe Hemophilia A Patients: A Multicenter Study.

Coincidental occurrence of severe factor XII deficiency in a case of mild hemophilia A: a unique coagulation laboratory diagnostic conundrum.

Immune tolerance induction for inhibitor eradication in nonsevere hemophilia A: a case series.

Structural Conformation and the Binding of Factor VIII R2159C (FVIII-Ise) Mutated in the C1 Domain to Phospholipid.

Extending health equity to people with moderate and mild hemophilia A: revisiting the HAVEN 6 trial.

Perioperative management of hemophilia A during coronary artery bypass grafting with patent foramen ovale repair.

Genotype-Dependent Response to Desmopressin in Hemophilia A and Proposal of a Predictive Response Score.

Bleeding Disorder of Unknown Cause: A Diagnosis of Exclusion.

Emicizumab use in females with moderate or mild hemophilia A without factor VIII inhibitors who warrant prophylaxis.

A Case of Congenital Mild Hemophilia Diagnosed After Wisdom Teeth Extraction.

Minimum factor VIII levels to prevent joint bleeding in mild hemophilia A.

Functional determination of emicizumab in presence of factor VIII activity.

Clinical pharmacology of emicizumab for the treatment of hemophilia A.

Cost-effectiveness of prophylactic emicizumab versus prophylactic recombinant factor VIII in patients with moderate or mild hemophilia A without inhibitors in the United States.

Managing Relevant Clinical Conditions of Hemophilia A/B Patients.

Surgical treatment of a distal radius and ipsilateral metacarpal hemophilic pseudotumor without recurrence or functional deficit: a case report.

Parapharyngeal hematoma following transesophageal echo in a patient with hemophilia A.

Treatment changes in hemophilia A with chromogenic factor VIII assay implementation.

Both one-stage and chromogenic factor VIII assays are required for the diagnosis of mild hemophilia A.

F8/F9 variants in the population-based PedNet Registry cohort compared with locus-specific genetic databases of the European Association for Haemophilia and Allied Disorders and the Centers for Disease Control and Prevention Hemophilia A or Hemophilia B Mutation Project.

Little discrepancy between one-stage and chromogenic factor VIII (FVIII)/IX assays in a large international cohort of persons with nonsevere hemophilia A and B.

Desmopressin as a hemostatic and blood sparing agent in bleeding disorders.

Esophageal ulcer associated with mild hemophilia A: case report.

Factor VIII and Factor IX Activity Measurements for Hemophilia Diagnosis and Related Treatments.

Phenotypic variation in severe hemophilia A is related to endogenous thrombin potential and plasma levels of factor VII.

[Spontaneous disappearance of the inhibitor during emicizumab therapy in a patient with mild hemophilia A].

The von Willebrand factor-binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A.

Desmopressin revisited in mild hemophilia A.

Clinical, cytogenetic, and genomic analyses of an Ecuadorian subject with Klinefelter syndrome, recessive hemophilia A, and 1;19 chromosomal translocation: a case report.

Moderate-intensity aerobic exercise vs desmopressin in adolescent males with mild hemophilia A: a randomized trial.

The bleeding phenotype in people with nonsevere hemophilia.

Next-generation sequencing of von Willebrand factor and coagulation factor VIII genes: a cross-sectional study in Croatian adult patients diagnosed with von Willebrand disease.

Management and outcomes of mild hemophiliacs and hemophilia carriers during pregnancy and peripartum period: a hemophilia treatment center experience in the United States.

Uncontrollable bleeding after tooth extraction from asymptomatic mild hemophilia patients: two case reports.

Desmopressin therapy in children and adults: pharmacological considerations and clinical implications.

Comparisons of global coagulation potential and bleeding episodes in emicizumab-treated hemophilia A patients and mild hemophilia A patients.

Silent variant in F8:c.222G>T (p.Thr74Thr) causes a partial exon skipping in a patient with mild hemophilia A.

Invisible bleeds: Lived experiences and barriers to care for men with hemophilia.

A founder effect in hemophilia A patients from Russian Ural region with a new p.(His634Arg) variant in F8 gene.

[Risk factors of inhibitor development among hemophilia patients revealed in a 10-year prospective cohort study in Japan, J-HIS2 (Japan Hemophilia Inhibitor Study 2)].

Delayed Bleeding in a Hemophilic Patient After Sinus Floor Elevation and Multiple Implant Placements: A Case Report.

Tamoxifen Therapy for Recurrent Mucosal Bleeding in Hereditary Hemorrhagic Telangiectasia.

ABO incompatibility and mild factor VIII deficiency in the neonate: Not too much of a problem but a challenge on ECMO.

Comparative analysis of chromogenic vs clot.based one stage APTT assay for determination of factor VIII level.

Major orthopedic surgery in a patient with fibromuscular dysplasia in the right renal artery and mild hemophilia A: First case reported.

Deep intronic F8 c.5999-27A>G variant causes exon 19 skipping and leads to moderate hemophilia A.

Investigation of discordant phenotype in mild Hemophilia A using whole exome sequencing.

Deep Brain Stimulation Surgery for Essential Tremor in a Patient with Type A Hemophilia.

The highly prevalent deletions in F8 intron 13 found in French mild hemophilia A patients result from both founder effect and recurrent de novo events.

Molecular Mechanisms of Inhibitor Development in Hemophilia.

Hemophilia A with a Rare Presentation of Hemarthrosis and Arthropathy Involving Multiple Joints in a Young Male Child.

[Mild hemophilia A diagnosed in an adult patient on the occasion of post-operative bleeding following a second knee surgery].

Deep intronic variant c.5999-277G>A of F8 gene may be a hot spot mutation for mild hemophilia A patients without mutation in exonic DNA.

The unusual pattern of hereditary bleeding disorders in the province of Newfoundland and Labrador-Canada's most Eastern Province.

The definition, diagnosis and management of mild hemophilia A: communication from the SSC of the ISTH.

Dental extractions in patients with mild hemophilia A and hemophilia B and von Willebrand disease without clotting factor supplementation.

Bilateral Forearm Pseudotumors in an Adult with Hemophilia A and Ollier Disease: A Case Report.

A novel type 2N VWF gene mutation: a case report.

Development of an FVIII Inhibitor in a Mild Hemophilia Patient with a Phe595Cys Mutation.

B6 and Bleeding: A Case Report of a Novel Vitamin Toxicity.

Successful Surgical Removal of A Massive Iliopsoas Pseudotumor in a Boy With Mild Hemophilia A.

Reccurrent F8 Intronic Deletion Found in Mild Hemophilia A Causes Alu Exonization.

[Study of gene mutation in 62 hemophilia A children].

Mild hemophilia A presaged by recurrent postoperative hemorrhagic complications in an elderly patient.

Revesz syndrome masquerading as traumatic retinal detachment.

Chromogenic Factor VIII Assays for Improved Diagnosis of Hemophilia A.

Cross-reacting Material-positive Hemophilia A Diagnosed in a Patient with a Spontaneous Thigh Hemorrhage.

Pitfalls in Interventional Pain Medicine: Hyponatremia after DDAVP for a Patient with Von Willebrand Disease Undergoing an Epidural Steroid Injection.

Nasal hemophilic pseudotumor in a patient with mild hemophilia A and allergic rhinitis.

Diagnosing von Willebrand disease: genetic analysis.

Combined variants in factor VIII and prostaglandin synthase-1 amplify hemorrhage severity across three generations of descendants.

Emerging Issues in Diagnosis, Biology, and Inhibitor Risk in Mild Hemophilia A.

Patients Referred for Bleeding Symptoms of Unknown Cause: Does Evaluation of Thrombin Generation Contribute to Diagnosis?

Costs and utilization of treatment in patients with hemophilia.

[Mild hemophilia A fortuitously discovered during Henoch-Schönlein purpura].

Mild hemophilia A patient with novel Pro1809Leu mutation develops an anti-C2 antibody inhibiting allogeneic but not autologous factor VIII activity.

Diagnostic evaluation of our patients with hemophilia A: 17-year experience.

Prevalence of IVS10nt-18G/A in Calabrian patients with moderate/mild hemophilia A and relation with Factor VIII inhibitor antibodies.

Assessment of Musculoskeletal Function and its Correlation with Radiological Joint Score in Children with Hemophilia A.

Overrepresentation of missense mutations in mild hemophilia A patients from Belgium: founder effect or independent occurrence?

Surgical Treatment of Intra-articular Knee Venous Malformations: When and How?